Chromadex Corp (NASDAQ:CDXC) currently has a daily average trading volume of 929.65K but it saw 1903269 shares traded in last market. With a market cap of 533.92M USD, the company’s current market price of $6.99 came rising about 14.40 while comparing to the previous closing price of $6.11. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.38 and as low as $1.32. In the recent trading on the day, stock has struck highest price mark of $6.13 while lowest mark touched by it was $7.08.
Taking a look at 20-day trading activity of Chromadex Corp (CDXC) gives us an average price of $4.03, while its current price level is 9.56% below from 52-week high level whereas it is 429.55% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $3.70 while that of 200 days or SMA-200 reads an average of $3.04. A closer look into the stock’s movement over the week reveals that its volatility is standing at 21.18% during that period while stretching the period over a month that decreases to 8.73%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 87.32 which implies that the stock is in overbought territory.
B. Riley Securities downgraded its recommendation for the stock as a “Neutral” from “Buy” on August 11, 2022 while assigning a price target range of $6-$2.40. ROTH Capital issued its recommendations for the stock as it initiated the price target for the stock is $7.
Over the week, CDXC’s stock price is moving 95.25% up while it is 113.76% when we observe its performance for the past one month. Year-to-date it is 388.81% up and over the past year, the stock is showing an upside performance of 362.91%.
Currently, Chromadex Corp’s total number of outstanding shares is 74.98M. Company’s return on investment (ROI) stands at 4.10% and return on equity (ROE) at 4.82%. It has a price to earnings ratio (P/E ratio) of 369.84 while having a 52.75 of forward P/E ratio. Stock’s beta reads 1.86. Stock has a price to book (P/B) ratio of 15.46 while price to sale or P/S ratio amounts to 5.82. Its return on asset (ROA) is 2.70% on average.
